Regeneron Seeks FDA Emergency Clearance for Covid-19 Therapy (1)

Regeneron Pharmaceuticals Inc. said it has asked federal regulators to authorize its antibody treatment for Covid-19 for emergency use.

President Donald Trump received the antibody cocktail last Friday under a compassionate use program after becoming sick with the coronavirus. Trump hailed Regeneron’s treatment in a video posted on Twitter Wednesday, saying he would authorize its emergency use and make it available to Americans for free.

Regeneron shares gained 3.5% in late trading in New York after the Trump video was posted.

The experimental therapy is one of several monoclonal antibody treatments in testing that may help treat patients with Covid-19. ...